nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—oviduct—ovarian cancer	0.053	0.18	CbGeAlD
Auranofin—PRDX5—myometrium—ovarian cancer	0.0169	0.0575	CbGeAlD
Auranofin—PRDX5—embryo—ovarian cancer	0.0163	0.0553	CbGeAlD
Auranofin—PRDX5—epithelium—ovarian cancer	0.0133	0.0452	CbGeAlD
Auranofin—PRDX5—uterine cervix—ovarian cancer	0.0132	0.0448	CbGeAlD
Auranofin—PRDX5—decidua—ovarian cancer	0.0126	0.0427	CbGeAlD
Auranofin—PRDX5—endometrium—ovarian cancer	0.0119	0.0405	CbGeAlD
Auranofin—PRDX5—gonad—ovarian cancer	0.0111	0.0376	CbGeAlD
Auranofin—PRDX5—uterus—ovarian cancer	0.011	0.0373	CbGeAlD
Auranofin—IKBKB—myometrium—ovarian cancer	0.01	0.0341	CbGeAlD
Auranofin—PRDX5—female reproductive system—ovarian cancer	0.00988	0.0335	CbGeAlD
Auranofin—IKBKB—embryo—ovarian cancer	0.00965	0.0328	CbGeAlD
Auranofin—PRDX5—bone marrow—ovarian cancer	0.00933	0.0317	CbGeAlD
Auranofin—PRDX5—female gonad—ovarian cancer	0.00899	0.0305	CbGeAlD
Auranofin—PRDX5—vagina—ovarian cancer	0.00894	0.0303	CbGeAlD
Auranofin—Nephrotic syndrome—Chlorambucil—ovarian cancer	0.00869	0.0277	CcSEcCtD
Auranofin—Interstitial pneumonia—Chlorambucil—ovarian cancer	0.00869	0.0277	CcSEcCtD
Auranofin—PRDX5—testis—ovarian cancer	0.00797	0.0271	CbGeAlD
Auranofin—IKBKB—uterine cervix—ovarian cancer	0.00781	0.0265	CbGeAlD
Auranofin—Interstitial pneumonia—Melphalan—ovarian cancer	0.00758	0.0241	CcSEcCtD
Auranofin—IKBKB—decidua—ovarian cancer	0.00744	0.0253	CbGeAlD
Auranofin—IKBKB—endometrium—ovarian cancer	0.00706	0.024	CbGeAlD
Auranofin—Pancytopenia—Altretamine—ovarian cancer	0.00704	0.0224	CcSEcCtD
Auranofin—IKBKB—gonad—ovarian cancer	0.00655	0.0222	CbGeAlD
Auranofin—IKBKB—uterus—ovarian cancer	0.00651	0.0221	CbGeAlD
Auranofin—Neuropathy peripheral—Altretamine—ovarian cancer	0.00648	0.0206	CcSEcCtD
Auranofin—Interstitial lung disease—Chlorambucil—ovarian cancer	0.00594	0.0189	CcSEcCtD
Auranofin—IKBKB—female reproductive system—ovarian cancer	0.00585	0.0199	CbGeAlD
Auranofin—PRDX5—lymph node—ovarian cancer	0.00578	0.0196	CbGeAlD
Auranofin—IKBKB—female gonad—ovarian cancer	0.00532	0.0181	CbGeAlD
Auranofin—IKBKB—vagina—ovarian cancer	0.00529	0.018	CbGeAlD
Auranofin—Interstitial lung disease—Topotecan—ovarian cancer	0.00529	0.0168	CcSEcCtD
Auranofin—Interstitial lung disease—Melphalan—ovarian cancer	0.00518	0.0165	CcSEcCtD
Auranofin—Anaemia—Altretamine—ovarian cancer	0.00478	0.0152	CcSEcCtD
Auranofin—IKBKB—testis—ovarian cancer	0.00472	0.016	CbGeAlD
Auranofin—Leukopenia—Altretamine—ovarian cancer	0.00463	0.0147	CcSEcCtD
Auranofin—Interstitial pneumonia—Paclitaxel—ovarian cancer	0.00445	0.0142	CcSEcCtD
Auranofin—Thrombocytopenia—Altretamine—ovarian cancer	0.00413	0.0131	CcSEcCtD
Auranofin—Anorexia—Altretamine—ovarian cancer	0.00402	0.0128	CcSEcCtD
Auranofin—Loose stools—Paclitaxel—ovarian cancer	0.00389	0.0124	CcSEcCtD
Auranofin—Interstitial pneumonia—Docetaxel—ovarian cancer	0.00377	0.012	CcSEcCtD
Auranofin—Decreased appetite—Altretamine—ovarian cancer	0.00367	0.0117	CcSEcCtD
Auranofin—IKBKB—lymph node—ovarian cancer	0.00342	0.0116	CbGeAlD
Auranofin—Interstitial lung disease—Paclitaxel—ovarian cancer	0.00304	0.00968	CcSEcCtD
Auranofin—Aplastic anaemia—Vinorelbine—ovarian cancer	0.003	0.00957	CcSEcCtD
Auranofin—ALB—testis—ovarian cancer	0.00276	0.00936	CbGeAlD
Auranofin—Vomiting—Altretamine—ovarian cancer	0.00268	0.00854	CcSEcCtD
Auranofin—Interstitial lung disease—Docetaxel—ovarian cancer	0.00258	0.00821	CcSEcCtD
Auranofin—Nausea—Altretamine—ovarian cancer	0.00251	0.00798	CcSEcCtD
Auranofin—Pancytopenia—Chlorambucil—ovarian cancer	0.0025	0.00797	CcSEcCtD
Auranofin—Neutropenia—Chlorambucil—ovarian cancer	0.00247	0.00785	CcSEcCtD
Auranofin—Neuropathy peripheral—Chlorambucil—ovarian cancer	0.0023	0.00734	CcSEcCtD
Auranofin—Jaundice—Chlorambucil—ovarian cancer	0.00229	0.00729	CcSEcCtD
Auranofin—Stomatitis—Chlorambucil—ovarian cancer	0.00229	0.00729	CcSEcCtD
Auranofin—Pancytopenia—Topotecan—ovarian cancer	0.00223	0.0071	CcSEcCtD
Auranofin—Neutropenia—Topotecan—ovarian cancer	0.00219	0.00699	CcSEcCtD
Auranofin—Pancytopenia—Melphalan—ovarian cancer	0.00218	0.00695	CcSEcCtD
Auranofin—Neutropenia—Melphalan—ovarian cancer	0.00215	0.00684	CcSEcCtD
Auranofin—Melaena—Paclitaxel—ovarian cancer	0.0021	0.00669	CcSEcCtD
Auranofin—Neuropathy peripheral—Topotecan—ovarian cancer	0.00205	0.00653	CcSEcCtD
Auranofin—Stomatitis—Topotecan—ovarian cancer	0.00204	0.00649	CcSEcCtD
Auranofin—Neuropathy peripheral—Melphalan—ovarian cancer	0.00201	0.00639	CcSEcCtD
Auranofin—Dysphagia—Vinorelbine—ovarian cancer	0.00201	0.00639	CcSEcCtD
Auranofin—ALB—lymph node—ovarian cancer	0.002	0.00678	CbGeAlD
Auranofin—Stomatitis—Melphalan—ovarian cancer	0.002	0.00636	CcSEcCtD
Auranofin—Jaundice—Melphalan—ovarian cancer	0.002	0.00636	CcSEcCtD
Auranofin—Pancytopenia—Vinorelbine—ovarian cancer	0.00191	0.00607	CcSEcCtD
Auranofin—Neutropenia—Vinorelbine—ovarian cancer	0.00188	0.00598	CcSEcCtD
Auranofin—Alopecia—Chlorambucil—ovarian cancer	0.00186	0.00594	CcSEcCtD
Auranofin—Weight decreased—Vinorelbine—ovarian cancer	0.00182	0.00578	CcSEcCtD
Auranofin—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00175	0.00559	CcSEcCtD
Auranofin—Stomatitis—Vinorelbine—ovarian cancer	0.00174	0.00556	CcSEcCtD
Auranofin—Anaemia—Chlorambucil—ovarian cancer	0.0017	0.00541	CcSEcCtD
Auranofin—Angioedema—Chlorambucil—ovarian cancer	0.00168	0.00534	CcSEcCtD
Auranofin—Agranulocytosis—Vinorelbine—ovarian cancer	0.00167	0.00532	CcSEcCtD
Auranofin—Alopecia—Topotecan—ovarian cancer	0.00166	0.00528	CcSEcCtD
Auranofin—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.00166	0.00527	CcSEcCtD
Auranofin—Leukopenia—Chlorambucil—ovarian cancer	0.00164	0.00523	CcSEcCtD
Auranofin—Alopecia—Melphalan—ovarian cancer	0.00163	0.00517	CcSEcCtD
Auranofin—Gingivitis—Epirubicin—ovarian cancer	0.00157	0.00499	CcSEcCtD
Auranofin—Anaemia—Topotecan—ovarian cancer	0.00151	0.00481	CcSEcCtD
Auranofin—Angioedema—Topotecan—ovarian cancer	0.00149	0.00476	CcSEcCtD
Auranofin—Anaemia—Melphalan—ovarian cancer	0.00148	0.00471	CcSEcCtD
Auranofin—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00147	0.00467	CcSEcCtD
Auranofin—Leukopenia—Topotecan—ovarian cancer	0.00146	0.00466	CcSEcCtD
Auranofin—Gingivitis—Doxorubicin—ovarian cancer	0.00145	0.00462	CcSEcCtD
Auranofin—Leukopenia—Melphalan—ovarian cancer	0.00143	0.00456	CcSEcCtD
Auranofin—Anorexia—Chlorambucil—ovarian cancer	0.00143	0.00455	CcSEcCtD
Auranofin—Alopecia—Vinorelbine—ovarian cancer	0.00142	0.00452	CcSEcCtD
Auranofin—Dysphagia—Paclitaxel—ovarian cancer	0.00135	0.0043	CcSEcCtD
Auranofin—Glossitis—Epirubicin—ovarian cancer	0.00134	0.00425	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.00132	0.00422	CcSEcCtD
Auranofin—Dyspepsia—Chlorambucil—ovarian cancer	0.00132	0.0042	CcSEcCtD
Auranofin—Thrombocytopenia—Topotecan—ovarian cancer	0.00131	0.00416	CcSEcCtD
Auranofin—Decreased appetite—Chlorambucil—ovarian cancer	0.0013	0.00415	CcSEcCtD
Auranofin—Anaemia—Vinorelbine—ovarian cancer	0.00129	0.00412	CcSEcCtD
Auranofin—Pancytopenia—Paclitaxel—ovarian cancer	0.00128	0.00408	CcSEcCtD
Auranofin—Thrombocytopenia—Melphalan—ovarian cancer	0.00128	0.00407	CcSEcCtD
Auranofin—Angioedema—Vinorelbine—ovarian cancer	0.00128	0.00407	CcSEcCtD
Auranofin—Anorexia—Topotecan—ovarian cancer	0.00127	0.00405	CcSEcCtD
Auranofin—Neutropenia—Paclitaxel—ovarian cancer	0.00126	0.00402	CcSEcCtD
Auranofin—Leukopenia—Vinorelbine—ovarian cancer	0.00125	0.00399	CcSEcCtD
Auranofin—Anorexia—Melphalan—ovarian cancer	0.00125	0.00397	CcSEcCtD
Auranofin—Glossitis—Doxorubicin—ovarian cancer	0.00124	0.00393	CcSEcCtD
Auranofin—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00123	0.0039	CcSEcCtD
Auranofin—Weight decreased—Paclitaxel—ovarian cancer	0.00122	0.00389	CcSEcCtD
Auranofin—Melaena—Epirubicin—ovarian cancer	0.0012	0.00383	CcSEcCtD
Auranofin—Urticaria—Chlorambucil—ovarian cancer	0.00119	0.00379	CcSEcCtD
Auranofin—Abdominal pain—Chlorambucil—ovarian cancer	0.00119	0.00377	CcSEcCtD
Auranofin—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00118	0.00376	CcSEcCtD
Auranofin—Dyspepsia—Topotecan—ovarian cancer	0.00117	0.00374	CcSEcCtD
Auranofin—Stomatitis—Paclitaxel—ovarian cancer	0.00117	0.00374	CcSEcCtD
Auranofin—Conjunctivitis—Paclitaxel—ovarian cancer	0.00117	0.00373	CcSEcCtD
Auranofin—Decreased appetite—Topotecan—ovarian cancer	0.00116	0.00369	CcSEcCtD
Auranofin—Aplastic anaemia—Epirubicin—ovarian cancer	0.00116	0.00368	CcSEcCtD
Auranofin—Dyspepsia—Melphalan—ovarian cancer	0.00115	0.00366	CcSEcCtD
Auranofin—Haematuria—Paclitaxel—ovarian cancer	0.00115	0.00365	CcSEcCtD
Auranofin—Dysphagia—Docetaxel—ovarian cancer	0.00114	0.00364	CcSEcCtD
Auranofin—Constipation—Topotecan—ovarian cancer	0.00114	0.00363	CcSEcCtD
Auranofin—Decreased appetite—Melphalan—ovarian cancer	0.00114	0.00362	CcSEcCtD
Auranofin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00112	0.00356	CcSEcCtD
Auranofin—Melaena—Doxorubicin—ovarian cancer	0.00111	0.00354	CcSEcCtD
Auranofin—Gastrointestinal pain—Topotecan—ovarian cancer	0.00109	0.00347	CcSEcCtD
Auranofin—Anorexia—Vinorelbine—ovarian cancer	0.00109	0.00346	CcSEcCtD
Auranofin—Pancytopenia—Docetaxel—ovarian cancer	0.00109	0.00346	CcSEcCtD
Auranofin—Neutropenia—Docetaxel—ovarian cancer	0.00107	0.00341	CcSEcCtD
Auranofin—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00107	0.0034	CcSEcCtD
Auranofin—Pruritus—Chlorambucil—ovarian cancer	0.00106	0.00338	CcSEcCtD
Auranofin—Urticaria—Topotecan—ovarian cancer	0.00106	0.00338	CcSEcCtD
Auranofin—Abdominal pain—Topotecan—ovarian cancer	0.00106	0.00336	CcSEcCtD
Auranofin—Visual impairment—Paclitaxel—ovarian cancer	0.00104	0.00332	CcSEcCtD
Auranofin—Urticaria—Melphalan—ovarian cancer	0.00104	0.00331	CcSEcCtD
Auranofin—Weight decreased—Docetaxel—ovarian cancer	0.00104	0.0033	CcSEcCtD
Auranofin—Diarrhoea—Chlorambucil—ovarian cancer	0.00103	0.00327	CcSEcCtD
Auranofin—Eye disorder—Paclitaxel—ovarian cancer	0.00101	0.00322	CcSEcCtD
Auranofin—Neuropathy peripheral—Docetaxel—ovarian cancer	0.001	0.00318	CcSEcCtD
Auranofin—Stomatitis—Docetaxel—ovarian cancer	0.000995	0.00317	CcSEcCtD
Auranofin—Jaundice—Docetaxel—ovarian cancer	0.000995	0.00317	CcSEcCtD
Auranofin—Decreased appetite—Vinorelbine—ovarian cancer	0.000992	0.00316	CcSEcCtD
Auranofin—Conjunctivitis—Docetaxel—ovarian cancer	0.000992	0.00316	CcSEcCtD
Auranofin—Constipation—Vinorelbine—ovarian cancer	0.000976	0.00311	CcSEcCtD
Auranofin—Alopecia—Paclitaxel—ovarian cancer	0.000955	0.00304	CcSEcCtD
Auranofin—Vomiting—Chlorambucil—ovarian cancer	0.000953	0.00303	CcSEcCtD
Auranofin—Agranulocytosis—Docetaxel—ovarian cancer	0.000952	0.00303	CcSEcCtD
Auranofin—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000947	0.00301	CcSEcCtD
Auranofin—Pruritus—Topotecan—ovarian cancer	0.000944	0.00301	CcSEcCtD
Auranofin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000934	0.00297	CcSEcCtD
Auranofin—Flatulence—Paclitaxel—ovarian cancer	0.000927	0.00295	CcSEcCtD
Auranofin—Pruritus—Melphalan—ovarian cancer	0.000925	0.00294	CcSEcCtD
Auranofin—Dysgeusia—Paclitaxel—ovarian cancer	0.000921	0.00293	CcSEcCtD
Auranofin—Diarrhoea—Topotecan—ovarian cancer	0.000913	0.00291	CcSEcCtD
Auranofin—Urticaria—Vinorelbine—ovarian cancer	0.000907	0.00289	CcSEcCtD
Auranofin—Abdominal pain—Vinorelbine—ovarian cancer	0.000903	0.00287	CcSEcCtD
Auranofin—Diarrhoea—Melphalan—ovarian cancer	0.000894	0.00285	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000893	0.00284	CcSEcCtD
Auranofin—Nausea—Chlorambucil—ovarian cancer	0.000891	0.00284	CcSEcCtD
Auranofin—Visual impairment—Docetaxel—ovarian cancer	0.000883	0.00281	CcSEcCtD
Auranofin—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000876	0.00279	CcSEcCtD
Auranofin—Anaemia—Paclitaxel—ovarian cancer	0.00087	0.00277	CcSEcCtD
Auranofin—Angioedema—Paclitaxel—ovarian cancer	0.00086	0.00274	CcSEcCtD
Auranofin—Eye disorder—Docetaxel—ovarian cancer	0.000856	0.00273	CcSEcCtD
Auranofin—Vomiting—Topotecan—ovarian cancer	0.000849	0.0027	CcSEcCtD
Auranofin—Leukopenia—Paclitaxel—ovarian cancer	0.000842	0.00268	CcSEcCtD
Auranofin—Rash—Topotecan—ovarian cancer	0.000842	0.00268	CcSEcCtD
Auranofin—Dermatitis—Topotecan—ovarian cancer	0.000841	0.00268	CcSEcCtD
Auranofin—Vomiting—Melphalan—ovarian cancer	0.000831	0.00265	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000827	0.00263	CcSEcCtD
Auranofin—Rash—Melphalan—ovarian cancer	0.000824	0.00262	CcSEcCtD
Auranofin—Dermatitis—Melphalan—ovarian cancer	0.000823	0.00262	CcSEcCtD
Auranofin—Alopecia—Docetaxel—ovarian cancer	0.00081	0.00258	CcSEcCtD
Auranofin—Pruritus—Vinorelbine—ovarian cancer	0.000808	0.00257	CcSEcCtD
Auranofin—Nausea—Topotecan—ovarian cancer	0.000793	0.00252	CcSEcCtD
Auranofin—Diarrhoea—Vinorelbine—ovarian cancer	0.000781	0.00249	CcSEcCtD
Auranofin—Dysgeusia—Docetaxel—ovarian cancer	0.000781	0.00249	CcSEcCtD
Auranofin—Nausea—Melphalan—ovarian cancer	0.000776	0.00247	CcSEcCtD
Auranofin—Dysphagia—Epirubicin—ovarian cancer	0.000772	0.00246	CcSEcCtD
Auranofin—Eosinophilia—Epirubicin—ovarian cancer	0.000764	0.00243	CcSEcCtD
Auranofin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000752	0.00239	CcSEcCtD
Auranofin—Anaemia—Docetaxel—ovarian cancer	0.000737	0.00235	CcSEcCtD
Auranofin—Pancytopenia—Epirubicin—ovarian cancer	0.000733	0.00233	CcSEcCtD
Auranofin—Anorexia—Paclitaxel—ovarian cancer	0.000732	0.00233	CcSEcCtD
Auranofin—Vomiting—Vinorelbine—ovarian cancer	0.000726	0.00231	CcSEcCtD
Auranofin—Neutropenia—Epirubicin—ovarian cancer	0.000722	0.0023	CcSEcCtD
Auranofin—Rash—Vinorelbine—ovarian cancer	0.00072	0.00229	CcSEcCtD
Auranofin—Dermatitis—Vinorelbine—ovarian cancer	0.000719	0.00229	CcSEcCtD
Auranofin—Dysphagia—Doxorubicin—ovarian cancer	0.000714	0.00227	CcSEcCtD
Auranofin—Leukopenia—Docetaxel—ovarian cancer	0.000714	0.00227	CcSEcCtD
Auranofin—Eosinophilia—Doxorubicin—ovarian cancer	0.000707	0.00225	CcSEcCtD
Auranofin—Weight decreased—Epirubicin—ovarian cancer	0.000698	0.00222	CcSEcCtD
Auranofin—Pancytopenia—Doxorubicin—ovarian cancer	0.000678	0.00216	CcSEcCtD
Auranofin—Nausea—Vinorelbine—ovarian cancer	0.000678	0.00216	CcSEcCtD
Auranofin—Dyspepsia—Paclitaxel—ovarian cancer	0.000676	0.00215	CcSEcCtD
Auranofin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000675	0.00215	CcSEcCtD
Auranofin—Jaundice—Epirubicin—ovarian cancer	0.000671	0.00214	CcSEcCtD
Auranofin—Stomatitis—Epirubicin—ovarian cancer	0.000671	0.00214	CcSEcCtD
Auranofin—Conjunctivitis—Epirubicin—ovarian cancer	0.000669	0.00213	CcSEcCtD
Auranofin—Neutropenia—Doxorubicin—ovarian cancer	0.000668	0.00213	CcSEcCtD
Auranofin—Decreased appetite—Paclitaxel—ovarian cancer	0.000668	0.00213	CcSEcCtD
Auranofin—Constipation—Paclitaxel—ovarian cancer	0.000657	0.00209	CcSEcCtD
Auranofin—Haematuria—Epirubicin—ovarian cancer	0.000656	0.00209	CcSEcCtD
Auranofin—Weight decreased—Doxorubicin—ovarian cancer	0.000646	0.00206	CcSEcCtD
Auranofin—Agranulocytosis—Epirubicin—ovarian cancer	0.000642	0.00205	CcSEcCtD
Auranofin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000637	0.00203	CcSEcCtD
Auranofin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000628	0.002	CcSEcCtD
Auranofin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000624	0.00199	CcSEcCtD
Auranofin—Stomatitis—Doxorubicin—ovarian cancer	0.000621	0.00198	CcSEcCtD
Auranofin—Jaundice—Doxorubicin—ovarian cancer	0.000621	0.00198	CcSEcCtD
Auranofin—Anorexia—Docetaxel—ovarian cancer	0.00062	0.00198	CcSEcCtD
Auranofin—Conjunctivitis—Doxorubicin—ovarian cancer	0.000619	0.00197	CcSEcCtD
Auranofin—Urticaria—Paclitaxel—ovarian cancer	0.00061	0.00194	CcSEcCtD
Auranofin—Haematuria—Doxorubicin—ovarian cancer	0.000607	0.00193	CcSEcCtD
Auranofin—Abdominal pain—Paclitaxel—ovarian cancer	0.000607	0.00193	CcSEcCtD
Auranofin—Visual impairment—Epirubicin—ovarian cancer	0.000596	0.0019	CcSEcCtD
Auranofin—Agranulocytosis—Doxorubicin—ovarian cancer	0.000594	0.00189	CcSEcCtD
Auranofin—Eye disorder—Epirubicin—ovarian cancer	0.000578	0.00184	CcSEcCtD
Auranofin—Dyspepsia—Docetaxel—ovarian cancer	0.000573	0.00182	CcSEcCtD
Auranofin—Decreased appetite—Docetaxel—ovarian cancer	0.000566	0.0018	CcSEcCtD
Auranofin—Constipation—Docetaxel—ovarian cancer	0.000557	0.00177	CcSEcCtD
Auranofin—Visual impairment—Doxorubicin—ovarian cancer	0.000551	0.00175	CcSEcCtD
Auranofin—Alopecia—Epirubicin—ovarian cancer	0.000546	0.00174	CcSEcCtD
Auranofin—Pruritus—Paclitaxel—ovarian cancer	0.000543	0.00173	CcSEcCtD
Auranofin—Eye disorder—Doxorubicin—ovarian cancer	0.000534	0.0017	CcSEcCtD
Auranofin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000532	0.00169	CcSEcCtD
Auranofin—Flatulence—Epirubicin—ovarian cancer	0.00053	0.00169	CcSEcCtD
Auranofin—Dysgeusia—Epirubicin—ovarian cancer	0.000527	0.00168	CcSEcCtD
Auranofin—Diarrhoea—Paclitaxel—ovarian cancer	0.000525	0.00167	CcSEcCtD
Auranofin—Abdominal pain—Docetaxel—ovarian cancer	0.000515	0.00164	CcSEcCtD
Auranofin—Alopecia—Doxorubicin—ovarian cancer	0.000505	0.00161	CcSEcCtD
Auranofin—Anaemia—Epirubicin—ovarian cancer	0.000497	0.00158	CcSEcCtD
Auranofin—Flatulence—Doxorubicin—ovarian cancer	0.00049	0.00156	CcSEcCtD
Auranofin—Vomiting—Paclitaxel—ovarian cancer	0.000488	0.00155	CcSEcCtD
Auranofin—Dysgeusia—Doxorubicin—ovarian cancer	0.000487	0.00155	CcSEcCtD
Auranofin—Rash—Paclitaxel—ovarian cancer	0.000484	0.00154	CcSEcCtD
Auranofin—Dermatitis—Paclitaxel—ovarian cancer	0.000484	0.00154	CcSEcCtD
Auranofin—Leukopenia—Epirubicin—ovarian cancer	0.000482	0.00153	CcSEcCtD
Auranofin—Pruritus—Docetaxel—ovarian cancer	0.000461	0.00147	CcSEcCtD
Auranofin—Anaemia—Doxorubicin—ovarian cancer	0.00046	0.00146	CcSEcCtD
Auranofin—Nausea—Paclitaxel—ovarian cancer	0.000456	0.00145	CcSEcCtD
Auranofin—Leukopenia—Doxorubicin—ovarian cancer	0.000446	0.00142	CcSEcCtD
Auranofin—Diarrhoea—Docetaxel—ovarian cancer	0.000445	0.00142	CcSEcCtD
Auranofin—Thrombocytopenia—Epirubicin—ovarian cancer	0.00043	0.00137	CcSEcCtD
Auranofin—Anorexia—Epirubicin—ovarian cancer	0.000418	0.00133	CcSEcCtD
Auranofin—Vomiting—Docetaxel—ovarian cancer	0.000414	0.00132	CcSEcCtD
Auranofin—Rash—Docetaxel—ovarian cancer	0.00041	0.00131	CcSEcCtD
Auranofin—Dermatitis—Docetaxel—ovarian cancer	0.00041	0.00131	CcSEcCtD
Auranofin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000398	0.00127	CcSEcCtD
Auranofin—Anorexia—Doxorubicin—ovarian cancer	0.000387	0.00123	CcSEcCtD
Auranofin—Nausea—Docetaxel—ovarian cancer	0.000387	0.00123	CcSEcCtD
Auranofin—Dyspepsia—Epirubicin—ovarian cancer	0.000386	0.00123	CcSEcCtD
Auranofin—Decreased appetite—Epirubicin—ovarian cancer	0.000382	0.00122	CcSEcCtD
Auranofin—Constipation—Epirubicin—ovarian cancer	0.000375	0.0012	CcSEcCtD
Auranofin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000359	0.00114	CcSEcCtD
Auranofin—Dyspepsia—Doxorubicin—ovarian cancer	0.000358	0.00114	CcSEcCtD
Auranofin—Decreased appetite—Doxorubicin—ovarian cancer	0.000353	0.00112	CcSEcCtD
Auranofin—Urticaria—Epirubicin—ovarian cancer	0.000349	0.00111	CcSEcCtD
Auranofin—Constipation—Doxorubicin—ovarian cancer	0.000347	0.00111	CcSEcCtD
Auranofin—Abdominal pain—Epirubicin—ovarian cancer	0.000347	0.0011	CcSEcCtD
Auranofin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000332	0.00106	CcSEcCtD
Auranofin—Urticaria—Doxorubicin—ovarian cancer	0.000323	0.00103	CcSEcCtD
Auranofin—Abdominal pain—Doxorubicin—ovarian cancer	0.000321	0.00102	CcSEcCtD
Auranofin—Pruritus—Epirubicin—ovarian cancer	0.000311	0.000989	CcSEcCtD
Auranofin—Diarrhoea—Epirubicin—ovarian cancer	0.0003	0.000956	CcSEcCtD
Auranofin—Pruritus—Doxorubicin—ovarian cancer	0.000287	0.000915	CcSEcCtD
Auranofin—Vomiting—Epirubicin—ovarian cancer	0.000279	0.000889	CcSEcCtD
Auranofin—Diarrhoea—Doxorubicin—ovarian cancer	0.000278	0.000885	CcSEcCtD
Auranofin—Rash—Epirubicin—ovarian cancer	0.000277	0.000881	CcSEcCtD
Auranofin—Dermatitis—Epirubicin—ovarian cancer	0.000277	0.00088	CcSEcCtD
Auranofin—Nausea—Epirubicin—ovarian cancer	0.000261	0.00083	CcSEcCtD
Auranofin—Vomiting—Doxorubicin—ovarian cancer	0.000258	0.000822	CcSEcCtD
Auranofin—Rash—Doxorubicin—ovarian cancer	0.000256	0.000815	CcSEcCtD
Auranofin—Dermatitis—Doxorubicin—ovarian cancer	0.000256	0.000815	CcSEcCtD
Auranofin—Nausea—Doxorubicin—ovarian cancer	0.000241	0.000768	CcSEcCtD
Auranofin—IKBKB—MyD88-independent cascade—IL6—ovarian cancer	0.000192	0.000492	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—AKT1—ovarian cancer	0.000192	0.00049	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—MAPK1—ovarian cancer	0.000191	0.000488	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—MAPK1—ovarian cancer	0.000189	0.000482	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—AKT1—ovarian cancer	0.000188	0.000481	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL6—ovarian cancer	0.000188	0.00048	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—HRAS—ovarian cancer	0.000188	0.000479	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PVRL2—ovarian cancer	0.000187	0.000477	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—MAPK1—ovarian cancer	0.000186	0.000474	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—ovarian cancer	0.000181	0.000462	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—AKT1—ovarian cancer	0.000181	0.000461	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—NRAS—ovarian cancer	0.00018	0.00046	CbGpPWpGaD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.00018	0.000459	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—ovarian cancer	0.00018	0.000459	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—MAPK3—ovarian cancer	0.000179	0.000458	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PTEN—ovarian cancer	0.000179	0.000458	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CD—ovarian cancer	0.000178	0.000455	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CD—ovarian cancer	0.000175	0.000447	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—VEGFA—ovarian cancer	0.000174	0.000446	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—ovarian cancer	0.000173	0.000443	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—ovarian cancer	0.000173	0.000443	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	0.000173	0.000442	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—ovarian cancer	0.000173	0.000441	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MAPK3—ovarian cancer	0.000172	0.000441	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—MAPK1—ovarian cancer	0.000171	0.000436	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PPP2R1A—ovarian cancer	0.00017	0.000434	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—ovarian cancer	0.000168	0.000429	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	0.000166	0.000425	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—PIK3CA—ovarian cancer	0.000166	0.000423	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK3—ovarian cancer	0.000165	0.000423	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—ovarian cancer	0.000165	0.000421	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MAPK1—ovarian cancer	0.000164	0.000419	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—EGFR—ovarian cancer	0.000164	0.000419	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PPP2R1A—ovarian cancer	0.000163	0.000417	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—ovarian cancer	0.000163	0.000416	CbGpPWpGaD
Auranofin—ALB—Metabolism—NME2—ovarian cancer	0.000162	0.000415	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—NRAS—ovarian cancer	0.00016	0.000408	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PARK2—ovarian cancer	0.000159	0.000408	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000157	0.000402	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK1—ovarian cancer	0.000157	0.000402	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—ovarian cancer	0.000157	0.000402	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—ovarian cancer	0.000156	0.000398	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CB—ovarian cancer	0.000155	0.000397	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—KRAS—ovarian cancer	0.000155	0.000396	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ERBB2—ovarian cancer	0.000155	0.000395	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DOK1—ovarian cancer	0.000154	0.000393	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—ovarian cancer	0.000154	0.000393	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CB—ovarian cancer	0.000153	0.00039	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MTOR—ovarian cancer	0.000153	0.00039	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—HRAS—ovarian cancer	0.000149	0.000381	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—ovarian cancer	0.000149	0.00038	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—PIK3CA—ovarian cancer	0.000148	0.000378	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—ovarian cancer	0.000147	0.000375	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—EGFR—ovarian cancer	0.000146	0.000372	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD8A—ovarian cancer	0.000145	0.000371	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—ovarian cancer	0.000145	0.000371	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PPP1CC—ovarian cancer	0.000145	0.00037	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CDKN1B—ovarian cancer	0.000143	0.000366	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—ovarian cancer	0.000143	0.000366	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL2—ovarian cancer	0.000143	0.000364	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—ovarian cancer	0.000141	0.00036	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CASP3—ovarian cancer	0.00014	0.000359	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IKBKG—ovarian cancer	0.00014	0.000358	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EREG—ovarian cancer	0.00014	0.000358	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SPARC—ovarian cancer	0.000138	0.000352	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000138	0.000352	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—ovarian cancer	0.000138	0.000352	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KRAS—ovarian cancer	0.000138	0.000352	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—HRAS—ovarian cancer	0.000137	0.00035	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SKP2—ovarian cancer	0.000137	0.000349	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—ovarian cancer	0.000137	0.000349	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—ovarian cancer	0.000135	0.000346	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ovarian cancer	0.000132	0.000338	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PTEN—ovarian cancer	0.000132	0.000337	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—AKT1—ovarian cancer	0.000132	0.000336	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	0.000129	0.000331	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PIK3CA—ovarian cancer	0.000126	0.000323	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—ovarian cancer	0.000126	0.000323	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TLR4—ovarian cancer	0.000123	0.000315	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—AKT1—ovarian cancer	0.000121	0.000309	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—ovarian cancer	0.000121	0.000309	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—STAT3—ovarian cancer	0.00012	0.000307	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—NRAS—ovarian cancer	0.00012	0.000306	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6ST—ovarian cancer	0.000118	0.000302	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—STAT3—ovarian cancer	0.000118	0.000301	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NRAS—ovarian cancer	0.000118	0.000301	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—HRAS—ovarian cancer	0.000117	0.000299	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ovarian cancer	0.000117	0.000299	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—AKT1—ovarian cancer	0.000116	0.000297	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—MAPK3—ovarian cancer	0.000115	0.000293	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.000114	0.000291	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK3—ovarian cancer	0.000113	0.000288	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000112	0.000287	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	0.000112	0.000286	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—ovarian cancer	0.000112	0.000285	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HDAC6—ovarian cancer	0.00011	0.00028	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—MAPK1—ovarian cancer	0.000109	0.000279	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK1—ovarian cancer	0.000107	0.000274	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—ovarian cancer	0.000107	0.000274	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000105	0.000268	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYTB—ovarian cancer	0.000105	0.000267	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—ovarian cancer	0.000103	0.000264	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—KRAS—ovarian cancer	0.000103	0.000263	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000102	0.000261	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000101	0.000259	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KRAS—ovarian cancer	0.000101	0.000259	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDH1—ovarian cancer	0.0001	0.000257	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SOD1—ovarian cancer	0.0001	0.000256	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CD—ovarian cancer	9.99e-05	0.000255	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PPP2R1A—ovarian cancer	9.96e-05	0.000255	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	9.91e-05	0.000253	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PPP2R1A—ovarian cancer	9.89e-05	0.000253	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—YAP1—ovarian cancer	9.71e-05	0.000248	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CD—ovarian cancer	9.59e-05	0.000245	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—XIAP—ovarian cancer	9.51e-05	0.000243	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CA—ovarian cancer	9.46e-05	0.000242	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CA—ovarian cancer	9.3e-05	0.000238	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SMARCA4—ovarian cancer	9.27e-05	0.000237	CbGpPWpGaD
Auranofin—ALB—Metabolism—BRIP1—ovarian cancer	9.15e-05	0.000234	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPP1CC—ovarian cancer	9.15e-05	0.000234	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	9.1e-05	0.000233	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EREG—ovarian cancer	9.04e-05	0.000231	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ERBB2—ovarian cancer	8.82e-05	0.000225	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—ovarian cancer	8.81e-05	0.000225	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—ovarian cancer	8.75e-05	0.000224	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CB—ovarian cancer	8.7e-05	0.000222	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MTOR—ovarian cancer	8.7e-05	0.000222	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—ovarian cancer	8.61e-05	0.00022	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PGR—ovarian cancer	8.48e-05	0.000217	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ERBB2—ovarian cancer	8.47e-05	0.000216	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—ovarian cancer	8.38e-05	0.000214	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CB—ovarian cancer	8.36e-05	0.000214	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MTOR—ovarian cancer	8.36e-05	0.000214	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—ovarian cancer	8.24e-05	0.000211	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1B—ovarian cancer	8.17e-05	0.000209	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	8.01e-05	0.000205	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PARP1—ovarian cancer	7.88e-05	0.000201	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1B—ovarian cancer	7.84e-05	0.0002	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	7.74e-05	0.000198	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CTNNB1—ovarian cancer	7.72e-05	0.000197	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—ovarian cancer	7.6e-05	0.000194	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PTEN—ovarian cancer	7.52e-05	0.000192	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CAV1—ovarian cancer	7.32e-05	0.000187	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	7.32e-05	0.000187	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PTEN—ovarian cancer	7.22e-05	0.000185	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR4—ovarian cancer	7.18e-05	0.000184	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	6.96e-05	0.000178	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6ST—ovarian cancer	6.89e-05	0.000176	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NRAS—ovarian cancer	6.71e-05	0.000171	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CG—ovarian cancer	6.67e-05	0.00017	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.67e-05	0.00017	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NRAS—ovarian cancer	6.44e-05	0.000165	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK3—ovarian cancer	6.43e-05	0.000164	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PPP2R1A—ovarian cancer	6.39e-05	0.000163	CbGpPWpGaD
Auranofin—ALB—Metabolism—YAP1—ovarian cancer	6.13e-05	0.000157	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK1—ovarian cancer	6.12e-05	0.000156	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—ovarian cancer	6.11e-05	0.000156	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDH1—ovarian cancer	6.09e-05	0.000156	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.07e-05	0.000155	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	6.04e-05	0.000154	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—ovarian cancer	5.87e-05	0.00015	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CD—ovarian cancer	5.86e-05	0.00015	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CD—ovarian cancer	5.82e-05	0.000149	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—ovarian cancer	5.78e-05	0.000148	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—ovarian cancer	5.55e-05	0.000142	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.34e-05	0.000136	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CA—ovarian cancer	5.31e-05	0.000136	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB2—ovarian cancer	5.14e-05	0.000131	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CB—ovarian cancer	5.11e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CA—ovarian cancer	5.1e-05	0.00013	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TERT—ovarian cancer	5.08e-05	0.00013	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CB—ovarian cancer	5.07e-05	0.00013	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MTOR—ovarian cancer	5.07e-05	0.00013	CbGpPWpGaD
Auranofin—ALB—Metabolism—FASN—ovarian cancer	5e-05	0.000128	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	4.94e-05	0.000126	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC5A5—ovarian cancer	4.92e-05	0.000126	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—ovarian cancer	4.91e-05	0.000125	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1B—ovarian cancer	4.76e-05	0.000122	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC2A1—ovarian cancer	4.75e-05	0.000121	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—ovarian cancer	4.71e-05	0.00012	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—ovarian cancer	4.7e-05	0.00012	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CAV1—ovarian cancer	4.7e-05	0.00012	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—ovarian cancer	4.69e-05	0.00012	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—ovarian cancer	4.66e-05	0.000119	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.65e-05	0.000119	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP1B1—ovarian cancer	4.55e-05	0.000116	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ESR1—ovarian cancer	4.53e-05	0.000116	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTNNB1—ovarian cancer	4.49e-05	0.000115	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6ST—ovarian cancer	4.45e-05	0.000114	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTEN—ovarian cancer	4.38e-05	0.000112	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—ovarian cancer	4.33e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CG—ovarian cancer	4.28e-05	0.000109	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APC—ovarian cancer	4.28e-05	0.000109	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—ovarian cancer	4.16e-05	0.000106	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPP2R1A—ovarian cancer	4.04e-05	0.000103	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.02e-05	0.000103	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—ovarian cancer	3.99e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NRAS—ovarian cancer	3.94e-05	0.000101	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT3—ovarian cancer	3.92e-05	0.0001	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NRAS—ovarian cancer	3.91e-05	9.99e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK3—ovarian cancer	3.77e-05	9.64e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CD—ovarian cancer	3.76e-05	9.61e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCB1—ovarian cancer	3.75e-05	9.59e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK3—ovarian cancer	3.74e-05	9.57e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—TYMS—ovarian cancer	3.68e-05	9.41e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK1—ovarian cancer	3.59e-05	9.17e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK1—ovarian cancer	3.56e-05	9.1e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—ovarian cancer	3.56e-05	9.1e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—ovarian cancer	3.39e-05	8.67e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—ovarian cancer	3.36e-05	8.6e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB2—ovarian cancer	3.32e-05	8.49e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CB—ovarian cancer	3.28e-05	8.38e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MTOR—ovarian cancer	3.28e-05	8.38e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL8—ovarian cancer	3.15e-05	8.05e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CA—ovarian cancer	3.12e-05	7.96e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CA—ovarian cancer	3.09e-05	7.9e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1B—ovarian cancer	3.08e-05	7.86e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—ovarian cancer	3.01e-05	7.7e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—ovarian cancer	3.01e-05	7.7e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—ovarian cancer	3.01e-05	7.69e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CAV1—ovarian cancer	2.97e-05	7.59e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—ovarian cancer	2.93e-05	7.5e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CTNNB1—ovarian cancer	2.91e-05	7.43e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—ovarian cancer	2.88e-05	7.37e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—ovarian cancer	2.86e-05	7.31e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—ovarian cancer	2.85e-05	7.28e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.84e-05	7.25e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTEN—ovarian cancer	2.83e-05	7.24e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—ovarian cancer	2.74e-05	6.99e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CG—ovarian cancer	2.7e-05	6.91e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—ovarian cancer	2.56e-05	6.54e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—ovarian cancer	2.54e-05	6.5e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT3—ovarian cancer	2.53e-05	6.47e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NRAS—ovarian cancer	2.53e-05	6.46e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—ovarian cancer	2.52e-05	6.45e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK3—ovarian cancer	2.42e-05	6.19e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CD—ovarian cancer	2.38e-05	6.07e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—ovarian cancer	2.35e-05	6.02e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK1—ovarian cancer	2.3e-05	5.89e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—ovarian cancer	2.3e-05	5.88e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—ovarian cancer	2.17e-05	5.56e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CB—ovarian cancer	2.07e-05	5.29e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CA—ovarian cancer	2e-05	5.11e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—ovarian cancer	1.93e-05	4.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—ovarian cancer	1.85e-05	4.72e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTEN—ovarian cancer	1.79e-05	4.58e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—ovarian cancer	1.77e-05	4.52e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—ovarian cancer	1.63e-05	4.17e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CA—ovarian cancer	1.26e-05	3.23e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—ovarian cancer	1.03e-05	2.64e-05	CbGpPWpGaD
